Showing results (1021-1030 of 2,691) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|December 18, 2025
Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023
The Lancet. Infectious Diseases|April 28, 2025
Immunogenicity and safety of different immunisation schedules of the VLA15 Lyme borreliosis vaccine candidate in adults, adolescents, and children: a randomised, observer-blind, placebo-controlled, phase 2 trialLaura Wagner, Michaela Obersriebnig, Vera Kadlecek, et al.
The Lancet. Infectious Diseases|April 7, 2025
Rethinking the evidence on COVID-19 in AfricaPhilip Bejon, Ambrose Agweyu, L Isabella Ochola-Oyier, et al.
The Lancet. Infectious Diseases|April 4, 2025
Rates of infection with other pathogens after a positive COVID-19 test versus a negative test in US veterans (November, 2021, to December, 2023): a retrospective cohort studyMiao Cai, Evan Xu, Yan Xie, et al.
The Lancet. Infectious Diseases|May 23, 2025
The health impact of identifying a person with tuberculosis through systematic screeningEmily A Kendall, David W Dowdy
The Lancet. Infectious Diseases|May 16, 2025
Consensus position statement on advancing the classification of patients and tests of cure in studies of antibiotic treatment of complicated urinary tract infectionsTruls E Bjerklund Johansen, Christina Bahrs, Franck Bruyere, et al.
The Lancet. Infectious Diseases|May 8, 2025
Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): a multicentre, retrospective, test-negative, case-control studyGonzalo Pérez Marc, Carla Vizzotti, Deshayne B Fell, et al.
The Lancet. Infectious Diseases|May 3, 2025
Estimated undertreatment of carbapenem-resistant Gram-negative bacterial infections in eight low-income and middle-income countries: a modelling studyAnant Mishra, Rahul Dwivedi, Kim Faure, et al.
The Lancet. Infectious Diseases|April 26, 2025
The effect of disease transmission on time-aggregated treatment efficacy estimates: a critical analysis of factors influencing the RTS,S and R21 malaria vaccine phase 3 trialsDídac Macià, Margarita Pons-Salort, Gemma Moncunill, et al.
The Lancet. Infectious Diseases|March 27, 2025
Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extensionAnne F Luetkemeyer, Deborah Donnell, Stephanie E Cohen, et al.
Pageof 270